Entity
Description
  • Value proposition

    French biotech company targeting the Adipocyte to treat insulin resistance, type 2 diabetes and associated comorbidities

    AdipoPharma SAS is a French biotech company with a US subsidiary committed to understanding the role of the adipocyte cells in diabetes via their unique effect on lipid biosynthesis and management of whole-body lipid homeostasis.

    Our first-in-class candidate - PATAS - is set to enter clinical trials later this year.

  • AdipoPharma, the adipocyte curing company

    By harnessing the power of the Adipocyte AdipoPharma is committed to developing innovative treatment for type 2 diabetes

  • https://www.adipopharma.com/
Corporate interactions BETA
Corporate TypeTweets Articles
BioValley France
BioValley France
Public business cluster, Biotechnology, French Cluster, Biotechnology Research
BioValley France
Public business cluster, Biotechnology, French Cluster, Biotechnology Research
Other

14 Aug 2024


MGEN
MGEN
Insurance
MGEN
Insurance
Other

25 Jun 2024


Mutuelle.fr
Mutuelle.fr
Insurance, Health, Mutual insurance
Mutuelle.fr
Insurance, Health, Mutual insurance
Other

25 Jun 2024


Bouygues Construction
Bouygues Construction
Construction, Real Estate
Bouygues Construction
Construction, Real Estate
Other

18 Jul 2024


Carglass® France Carglass® France
Other

13 May 2024


DECATHLON FRANCE
DECATHLON FRANCE
Retail and Distribution, Retail
DECATHLON FRANCE
Retail and Distribution, Retail
Other

27 Feb 2024


Welcome to the Jungle France
Welcome to the Jungle France
Human ressources, Software Development
Welcome to the Jungle France
Human ressources, Software Development
Other

28 Mar 2024


Ipsos France
Ipsos France
Polling institute, Research Services
Ipsos France
Polling institute, Research Services
Other

7 Feb 2024


Saint-Gobain
Saint-Gobain
Building supplies, Wholesale Building Materials
Saint-Gobain
Building supplies, Wholesale Building Materials
Other

29 Apr 2024


Réseau SATT Réseau SATT
Other

30 Jan 2023


Similar entities
Loading...
Loading...
Social network dynamics